GE HealthCare Technologies (GEHC) Stock Price, News & Analysis

Company Overview

GE HealthCare Technologies, Inc. (NASDAQ: GEHC) is a global medical technology and life sciences company that develops and delivers diagnostic imaging, radiotherapy, digital solutions and biopharmaceutical manufacturing technologies. Its product portfolio includes advanced magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, molecular imaging and X-ray systems, along with interventional and surgical imaging equipment designed to enhance diagnostic accuracy and patient care.

Beyond hardware, GE HealthCare provides software platforms that enable clinical data management, workflow optimization, artificial intelligence–driven analytics and remote patient monitoring. Its life sciences division supplies single-use technologies, cell therapy tools and customized processing systems for biopharmaceutical research, development and manufacturing, supporting pharmaceutical customers in bringing therapies from concept to commercialization.

Headquartered in Chicago, Illinois, GE HealthCare serves healthcare providers, research institutions and pharmaceutical companies in more than 160 countries through a combination of direct sales, service operations and channel partners. The business traces its origins to the early days of commercial X-ray and evolved as part of General Electric’s Healthcare division before becoming an independent public company in early 2023. Under the leadership of CEO Peter Arduini, the company continues to expand its global footprint and invest in innovation to address evolving healthcare challenges.

Key Stats

• Today's Range: $73.16 to $74.24
• 50-Day Range: $71.01 to $78.71
• 52-Week Range: $57.65 to $94.80
• Volume: 734,324 shs
• Average Volume: 3.88 million shs
• Market Capitalization: $33.27 billion
• P/E Ratio: 14.96
• Dividend Yield: 0.19%
• Price Target: $85.20
• Consensus Rating: Moderate Buy

GE HealthCare Technologies Stock Analysis - MarketRank™

GE HealthCare Technologies scored higher than 79% of companies evaluated by MarketBeat, and ranked 204th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

GE HealthCare Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 6 hold ratings, and no sell ratings.

Upside Potential

GE HealthCare Technologies has a consensus price target of $85.20, representing about 15.6% upside from its current price of $73.68.

Amount of Analyst Coverage

GE HealthCare Technologies has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 11.11%

Earnings Growth

Earnings for GE HealthCare Technologies are expected to grow by 11.11% in the coming year, from $4.68 to $5.20 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of GE HealthCare Technologies is 15.09, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.17.

Price to Earnings Ratio vs. Sector

The P/E ratio of GE HealthCare Technologies is 15.09, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 84.98.

Price to Earnings Growth Ratio

GE HealthCare Technologies has a PEG Ratio of 2.76. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

GE HealthCare Technologies has a P/B Ratio of 3.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.64% of the float of GE HealthCare Technologies has been sold short.

Short Interest Ratio / Days to Cover

GE HealthCare Technologies has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in GE HealthCare Technologies has recently increased by 1.36%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

GE HealthCare Technologies has a dividend yield of 0.19%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

GE HealthCare Technologies has only been increasing its dividend for 1 years.

Dividend Coverage

The dividend payout ratio of GE HealthCare Technologies is 2.87%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, GE HealthCare Technologies will have a dividend payout ratio of 2.69% next year. This indicates that GE HealthCare Technologies will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.64% of the float of GE HealthCare Technologies has been sold short.

Short Interest Ratio / Days to Cover

GE HealthCare Technologies has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in GE HealthCare Technologies has recently increased by 1.36%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.9 / 5
• News Sentiment: 1.02

News Sentiment

GE HealthCare Technologies has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 22 news articles for GE HealthCare Technologies this week, compared to 18 articles on an average week.

Search Interest

46 people have searched for GEHC on MarketBeat in the last 30 days. This is an increase of 142% compared to the previous 30 days.

MarketBeat Follows

10 people have added GE HealthCare Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, GE HealthCare Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.28% of the stock of GE HealthCare Technologies is held by insiders.

Percentage Held by Institutions

82.06% of the stock of GE HealthCare Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GEHC Stock Analysis - Frequently Asked Questions

How have GEHC shares performed this year?

GE HealthCare Technologies' stock was trading at $78.18 at the beginning of the year. Since then, GEHC shares have decreased by 5.8% and is now trading at $73.6790.

How were GE HealthCare Technologies' earnings last quarter?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced its quarterly earnings data on Wednesday, July, 30th. The company reported $1.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. The firm's revenue was up 3.5% compared to the same quarter last year.
Read the conference call transcript.

Is GE HealthCare Technologies doing a stock buyback?

GE HealthCare Technologies' board authorized a stock buyback plan on Wednesday, April 30th 2025, which authorizes the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 3.1% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board of directors believes its shares are undervalued.

Who are GE HealthCare Technologies' major shareholders?

GE HealthCare Technologies' top institutional shareholders include Douglas Lane & Associates LLC (0.10%), Wedge Capital Management L L P NC (0.08%), Salem Investment Counselors Inc. (0.04%) and Northside Capital Management LLC (0.03%). Insiders that own company stock include Frank R Jimenez, Taha Kass-Hout, Jan Makela, Roland Rott, Kevin Michael O'neill, Thomas J Westrick and H Lawrence Culp Jr.
View institutional ownership trends.

How do I buy shares of GE HealthCare Technologies?

Shares of GEHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of GE HealthCare Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that GE HealthCare Technologies investors own include Chevron (CVX), Bristol Myers Squibb (BMY), Humana (HUM), Comcast (CMCSA), American Water Works (AWK), McKesson (MCK) and Charles Schwab (SCHW).

Company Calendar

• Record date for 8/15 Dividend: 7/25/2025
• Ex-Dividend for 8/15 Dividend: 7/25/2025
• Last Earnings: 7/30/2025
• Dividend Payable: 8/15/2025
• Today: 10/16/2025
• Record date for 11/14 Dividend: 10/24/2025
• Ex-Dividend for 11/14 Dividend: 10/24/2025
• Next Earnings (Estimated): 10/29/2025
• Dividend Payable: 11/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:GEHC
• Previous Symbol: NASDAQ:GEHC
• CIK: 1932393
• Web: www.gehealthcare.com
• Phone: 833-735-1139
• Fax: N/A
• Employees: 53,000
• Year Founded: 1994

Price Target and Rating

• Average Price Target for GE HealthCare Technologies: $85.20
• High Price Target: $103.00
• Low Price Target: $73.00
• Potential Upside/Downside: +16.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.88
• Trailing P/E Ratio: 15.05
• Forward P/E Ratio: 15.68
• P/E Growth: 2.76
• Net Income: $1.99 billion
• Net Margins: 11.22%
• Pretax Margin: 14.00%
• Return on Equity: 23.93%
• Return on Assets: 6.29%

Debt

• Debt-to-Equity Ratio: 0.85
• Current Ratio: 1.16
• Quick Ratio: 0.93

Sales & Book Value

• Annual Sales: $19.67 billion
• Price / Sales: 1.70
• Cash Flow: $5.86 per share
• Price / Cash Flow: 12.52
• Book Value: $18.53 per share
• Price / Book: 3.96

Miscellaneous

• Outstanding Shares: 456,560,000
• Free Float: 455,284,000
• Market Cap: $33.50 billion
• Optionable: Optionable
• Beta: 1.13